- Home
- BWAY vs SABA Comparison
BWAY vs SABA Comparison
Compare BWAY & SABA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BWAY
- SABA
- Stock Information
- Founded
- BWAY 2003
- SABA 1988
- Country
- BWAY Israel
- SABA United States
- Employees
- BWAY N/A
- SABA N/A
- Industry
- BWAY Medical/Dental Instruments
- SABA
- Sector
- BWAY Health Care
- SABA
- Exchange
- BWAY Nasdaq
- SABA Nasdaq
- Market Cap
- BWAY 207.4M
- SABA 233.0M
- IPO Year
- BWAY 2019
- SABA N/A
- Fundamental
- Price
- BWAY $8.76
- SABA $8.62
- Analyst Decision
- BWAY Strong Buy
- SABA
- Analyst Count
- BWAY 3
- SABA 0
- Target Price
- BWAY $13.17
- SABA N/A
- AVG Volume (30 Days)
- BWAY 24.0K
- SABA 290.0K
- Earning Date
- BWAY 05-13-2025
- SABA 01-01-0001
- Dividend Yield
- BWAY N/A
- SABA 12.91%
- EPS Growth
- BWAY N/A
- SABA N/A
- EPS
- BWAY 0.06
- SABA N/A
- Revenue
- BWAY $41,016,000.00
- SABA N/A
- Revenue This Year
- BWAY $351.53
- SABA N/A
- Revenue Next Year
- BWAY $21.84
- SABA N/A
- P/E Ratio
- BWAY $57.69
- SABA N/A
- Revenue Growth
- BWAY 29.04
- SABA N/A
- 52 Week Low
- BWAY $5.13
- SABA $3.64
- 52 Week High
- BWAY $11.79
- SABA $4.42
- Technical
- Relative Strength Index (RSI)
- BWAY 47.80
- SABA 52.34
- Support Level
- BWAY $8.61
- SABA $8.52
- Resistance Level
- BWAY $9.09
- SABA $8.84
- Average True Range (ATR)
- BWAY 0.38
- SABA 0.19
- MACD
- BWAY 0.05
- SABA 0.04
- Stochastic Oscillator
- BWAY 58.73
- SABA 70.68
About BWAY BrainsWay Ltd.
BrainsWay Ltd is engaged in advanced noninvasive neurostimulation treatments for mental health disorders. The company is advancing neuroscience with its proprietary Deep Transcranial Magnetic Stimulation (Deep TMS) platform technology to improve health and transform lives. Current indications include depressive disorder (including reduction of anxiety symptoms, commonly referred to as anxious depression), obsessive-compulsive disorder and smoking addiction. Additional clinical trials of Deep TMS in various psychiatric, neurological, and addiction disorders are underway. The company derives revenues from the lease and sale of Deep TMS systems.
About SABA Saba Capital Income & Opportunities Fund II Shares of Beneficial Interest
Saba Capital Income & Opportunities Fund II is a closed-end fund. The company seeks high current income, with a secondary goal of capital appreciation. The fund invests in fixed income markets across the globe.